ABSTRACT We covalently linked to regenerated cellulose filters a high-affinity monoclonal IgM produced against epitopes that reside on hepatitis B viral surface antigen (HBsAg). Conditions were established whereby as much as 250 jig of anti-HBsAg IgM could be linked to 2-4 mg of regenerated cellulose acetate by using cyanogen bromide and trichloro-s-triazine coupling agents. The immunoreactivity of the monoclonal anti-HBsAg IgM was preserved, and quantitative binding studies with HBsAg suggests that more than one functional binding site on the IgM molecule was operative. The specificity of the monoclonal anti-HBsAg IgM was established by demonstrating that a nonspecific monoclonal IgM (against influenza hemagglutinin), when coupled to the filters under identical conditions, had no effect on removal of HBsAg from serum. Most importantly, the monoclonal anti-HBsAg IgM-coupled filters quantitatively removed low levels of HBsAg from serum; after the third pass through the filter, HBsAg was undetectable in the perfusate. Further, the stability of the covalent bond between the anti-HBsAg IgM and regenerated cellulose acetate was shown by the lack of detectable murine monoclonal anti-HBsAg IgM in filtered serum despite 50 passages through the filter. Thus, we have demonstrated that monoclonal IgM antibodies with predefined specificity, when coupled to a biocompatible solid-phase support, may serve as a high-affinity and specific immunoabsorbant for quantitative removal and recovery of viral antigens from human serum. By using this approach, specific removal and recovery of many other substances from serum or plasma would seem possible.
Plasma exchange has been used. as a nonspecific technique to remove antibodies, immune complexes, and other substances associated with or thought to cause various disease states (1) . For example, improvement in symptoms related to myasthenia gravis, rheumatoid arthritis, and systemic lupus erythematosus have been achieved after plasmapheresis (2, 3) . There are, however, several problems associated with this technique, which include (i) the limited removal of the specific and presumed pathogenic substance(s) compared to the required large plasma volume of exchange, (ii) the expense and limited availability of plasma products, (iii) the danger of loss of essential plasma components, and (iv) possible viral and bacterial contamination introduced by the procedure (1) . However, recent advances in plasmapheresis technology have lessened these limitations. Rapid low-pressure separation of plasma from formed blood elements is possible by using hollow-fiber filters of 0.2-,um mean pore size (4) (5) (6) (7) (8) . This allows on-line treatment of plasma with its eventual return to the patient. Separated from the formed elements in extracorporeal circulation, the plasma may be treated by a variety of procedures to remove substances associated with disease states. For example, an immunoabsorbant with polyvalent antibodies has been used to remove apolipoprotein from plasma (9, 10) . Other techniques utilized to remove from plasma molecules of clinical interest include (i) adsorption with activated charcoal and anion-exchange resins (6, 7) or (ii) cryofiltration after cryoprecipitation of immune complexes (5, 8) .
The techniques that have been used to remove unwanted components from plasma suffer from a lack of precise specificity and the availability of a sufficient amount of immunoabsorbant. Monoclonal antibodies of known predetermined specificity and high affinity might be used to overcome such problems and be utilized to selectively remove molecules of interest from plasma during extracorporeal circulation. We have begun to examine the feasibility of this approach. In a model system, an IgM monoclonal antibody has been covalently bound to regenerated cellulose membrane filters of previously demonstrated biocompatibility (11) . Indeed, larger versions of these filters have been used clinically in on-line filtration of gel in the treatment of rheumatoid arthritis (5, 6) . In the present report, we examined the specificity, stability, and capacity of a monoclonal anti-HBsAg IgM conjugated to a biocompatible support in an attempt to quantitatively remove HBsAg from serum.
MATERIALS AND METHODS
Materials. The immunization protocols, characteristics, and purity of the immunization antigen (HBsAg), the cell-fusion technique, and the growth and cloning of hybridomas producing anti-HBsAg antibodies have been reported (12) . Such antibodies have been characterized with respect to specificity for determinants on HBsAg, ability to agglutinate erythrocytes coated with HBsAg (subtypes adw and ayw), antibody class and subclass, and affinity for HBsAg-associated epitopes (12) (13) (14) (15) (16) (17) (18) (19) ). An anti-HBsAg IgM designated 5D3 was selected from a library of monoclonal antibodies because it recognized a common determinant on the following subtypes of HBsAg: adw2, adw4, adr, ayw1, ayw3, ayw4, ayr, and adyw (20) . Furthermore, the 5D3 anti-HBsAg IgM was found to have an affinity constant of 4 X 1011 liters/mol per molecule. The nonspecific monoclonal IgM directed against the influenza hemagglutinin (HA) was supplied by W. Gerhard. We used regenerated cellulose acetate membrane filters measuring 13 mm in diameter and weighing between 2 and 4 mg with a 0.25-,um pore size and placed them in a filter holder (Gelman) for these studies.
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Radioimmunoassays (RIA). For detection of HBsAg, we used monoclonal and AUSRIA II RIAs as described (12 Coupling of Antibodies to Filters. Dry membrane filters of regenerated cellulose acetate (Gelman) were precycled with 5-ml volumes of 0.1 M HCl, dH2O, and 0.1 M NaOH. The CNBr method was used to activate the free hydroxyl groups on the filters for coupling to the antibodies. In a modification of the method described by Porath (21) , the swollen filters were placed in 2 ml of cold, 3 M potassium phosphate buffer (pH 12.1). To this solution, 1 ml of CNBr in dH2O (100 mg/ml) was added slowly. After 12 min at 40C, the solution was decanted, and the filters were washed quickly with cold dH2O. The filters were then placed in 4 ml of monoclonal anti-HBsAg IgM (0.7-3.4 mg/ml) in 0.1 M sodium phosphate (pH 8.6)/0.1 M NaCl and incubated 24 hr at 4°C with gentle agitation. Alternatively, after activation some of the filters were placed in syringe filter holders (Gelman) and continuously perfused with 4 ml of monoclonal IgM-containing solutions at a rate of 0.05 ml/min for 24 hr at 4°C. The filters were then perfused extensively with phosphate-buffered saline to remove noncovalently bound monoclonal IgM antibodies.
A variation of the trichloro-s-triazine, N3C3C13, method of activation as described by Finlay was used also to activate filters for conjugation with antibody (22) . The swollen filters were washed with dH2O and transferred to dioxane by washing with successive 5-ml volumes of 20%, 40%, 60%, 80%, and 100% dioxane in dH2O (vol/vol). The filters were placed in 4.5 ml of dioxane; 1.5 ml of 2 M N,N'-diisopropylethylamine in dioxane was added, and the filters were incubated for 30 min at 50°C. One ml of 1 M N3C3C13 (Sigma) in dioxane was then added, and the filters were incubated for an additional 1 hr at 50°C. After the second incubation, the filters were washed with dioxane and transferred to 5 ml of 2 M aniline in dioxane. After 30 min at 200C, the activated filters were washed extensively with dioxane and transferred to dH2O by washing with successive 5-ml volumes of 80%, 60%, 40%, 20%, and 0% dioxane in dH20 (vol/vol). The N3C3C13-activated filter was.placed either in 4 ml of IgM-containing solution (0.7-2.5 mg/ml) and incubated at 200C for 48 hr or was perfused with 4 ml of the same solution at 0.05 ml/min for 48 hr at 200C.
We calculated the amount of anti-HBsAg IgM bound to the filters by two techniques. In the first, the monoclonal IgM was radiolabeled to known specific activity (4-10 ,Ci/,ug; 1 Ci = 3.7 X 1010 Bq) with the Hunter-Bolton reagent as described (23) . Radiolabeled antibody was added to cold anti-HBsAg IgM in solution prior to filter conjugation with CNBr or N3C3C13.
The amount of '"I-labeled anti-HBsAg IgM (1"I-IgM) bound to the intact filter was measured.by a Packard gamma. counter.
It was assumed that the percentage of '"I-IgM and unlabeled IgM bound to the filters was the same. To confirm these findings, a second procedure was used in which the IgM antibodyconjugated filters were hydrolyzed, and the amount of antibody bound was determined directly by amino acid analysis with a Dionex autoanalyzer.
Assessment of HBsAg Bound to Filters. We determined the amount of HBsAg bound to IgM antibody-conjugated filters directly by "2I-labeled HBsAg (125I-HBsAg) binding studies similar to those described above. A second approach also was used in which the concentration of HBsAg in serum was determined before and after perfusions through the filters. In these experiments a standard curve was constructed with known concentrations of HBsAg. The amount of HBsAg at each dilution was measured by both monoclonal and AUSRIA II RIAs as described (13) . Thus, the concentration of HBsAg bound to the filters was calculated from the pre-and post-perfusion HBsAg concentrations. In this regard-we also examined the HBsAg binding capacity of the anti-HBsAg IgM-conjugated filters. In such experiments an HBsAg-positive serum sample was diluted with phosphate-buffered saline containing 1% bovine serum albumin to reach a constant antigen concentration of 40 tg/ml. This solution was perfused at a rate of 0.5 ml/min. Twenty 2-ml fractions were collected, and the-HBsAg concentration of each fraction was measured by RIAs Fig. 1 shows the ultrastructural features of the unmodified and IgMconjugated regenerated cellulose acetate filters (compare Fig.  1 b and c) . As RIAs (13) was removed after three cycles through the filter in a closed-loop system as shown in Fig. 2 . In contrast, the concentration of HBsAg in serum was unaffected when perfused through filters to which a monoclonal IgM anti-influenza HA antibody had been attached at approximately the same concentration with the identical activation techniques. This finding demonstrates that quantitative removal of HBsAg from serum was due to a specific antigen-antibody interaction and not due to nonspecific trapping of HBsAg on the filter. HBsAg Binding Capacity of Filters. Fig. 3 shows the kinetics of HBsAg binding to the anti-HBsAg IgM-conjugated filters. The difference in the shape of the two curves is due in part to the amount of anti-HBsAg antibody immobilized to the solid-phase support. It is evident that the filter with 13 during the initial fraction, which we believe was due to mechanical manipulation of the filter when placed in the filtration apparatus. In support of this conclusion was the fact that no anti-HBsAg IgM was detected in the subsequent 50 passages as measured by two sensitive RIAs. It is highly unlikely, therefore, that continuous perfusion through these filters would allow for an immune response to murine monoclonal antibodies to develop in recipients. Regeneration In support of the specificity of this interaction is the fact that monoclonal anti-influenza HA IgM-coupled filters had no effect on the removal of HBsAg from serum.
Another important feature of this system is the stability of the anti-HBsAg IgM immobilized to this solid-phase support. We were unable to detect in the perfusate, except for that which was mechanically removed, even minute amounts of anti-HBsAg 1"I-IgM or unlabeled antibody by two sensitive RIAs despite 50 passes of serum through the filters. It is unlikely, therefore, that immunization of the host with murine monoclonal IgM would occur. The stability and immunoreactivity of the IgMconjugated filters also was preserved after elution of HBsAg with glycine'HCI buffer (pH 2.3). More importantly, the HBsAg was quantitatively recovered under these conditions and retained fully its immunoreactivity and morphology (Fig. 5) .
The findings reported here have important implications for extracorporeal circulation systems in general. It would be possible to selectively remove and recover almost any substance from plasma if one had the monoclonal antibodies of appropriate affinity and specificity. Thus, highly specific immunoabsorbants could be placed "on-line" to remove toxins, protein-bound drugs, growth factors, virus(es), hormones, cells, antibodies, and immunocomplexes. For example, such a system might be useful in the treatment of myasthenia gravis or insulin-resistant diabetes due to anti-receptor antibodies if the appropriate murine monoclonal anti-idiotypes were available. Finally, by using these techniques, selective removal and recovery of minute amounts of "tumor-associated" antigens (25, 26) to allow subsequent characterization and production of more specific antibodies for use in immunodiagnosis and therapy would seem possible.
